INPP4B, which was first described by Zhai et al., is an oncogenic gene in pancreatic cancer and could serve as a potential diagnostic marker and an independent prognostic marker, suggesting that it is a novel therapeutic target for pancreatic cancer28. The gene discussed is INPP4B; the disease is familial pancreatic carcinoma.